Clinical Trial Update: Effect of Dapagliflozin on Glycemic Variability [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effect of dapagliflozin on glycemic variability in adults with Type 2 Diabetes Mellitus, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED